Anzeige
Mehr »
Login
Montag, 09.09.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Tenbagger-ALARM! Aktie mit MEGA-Potenzial startet durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
206 Leser
Artikel bewerten:
(1)

Sipp Industries Inc: SIPP Industries Announces Milestone Achievements in Partnership with Calypso Pharmaceuticals

COSTA MESA, CA / ACCESSWIRE / August 1, 2024 / SIPP Industries, Inc. (OTC PINK:SIPC), a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products within the cannabis industry, proudly announces successful distribution and production milestones in collaboration with its partner, Calypso Pharmaceuticals.

SIPP Industries and Calypso Pharmaceuticals have gained significant momentum within the Texas Hemp Industry by securing multiple key distributors and high-volume, multi-location retail storefronts in Dallas and Fort Worth. These outlets will carry an extensive range of products, including the entire lineup of Calypso Farms THCa Flower/Pre-Rolls, Calypso Pharmaceuticals 100mg hemp-derived Delta-9 White Lightning Syringes, and AVEINA 1000mg CBD Infused Body Lotion.

Additionally, SIPP Industries and Calypso Pharmaceuticals is set to launch a new production partnership with CHLL Brand, offering innovative products like a 100mg Delta-9 Hemp Derived Water Soluble Flavor Enhancer and a 12oz 25mg CBD Infused Flavorless Bottle of Water.

The Water Soluble Flavor Enhancer, utilizing a 1:1 ratio of CBD to hemp derived Delta-9, is designed to assist with anxiety and depression. The CBD's anxiolytic effects may help alleviate anxiety symptoms, while Delta-9 could contribute to mood regulation, offering a balanced approach to mental well-being.

The Flavorless Bottle of Water, containing 25mg of CBD per bottle, provides a convenient way to incorporate CBD into daily routines, potentially offering general wellness benefits, including stress relief and relaxation without the psychoactive effects of THC, catering to those seeking a mild, non-intoxicating option.

With the rapid increase in volume and growth, SIPP Industries anticipates booking revenues during this quarter, with robust sales expected to commence in both Q4 and Q1 2025.

Adam Graziano, CEO of SIPP Industries, expressed his excitement about the Company's achievements: "This milestone marks a significant step forward for SIPP Industries and our partner, Calypso Pharmaceuticals. Our commitment to delivering high-quality cannabis-based products continues to drive our success in the market. We are thrilled to expand our offerings and reach more consumers, providing innovative solutions for health and wellness."

About SIPP Industries

SIPP Industries is a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products within the cannabis industry.

Website: https://www.sippindustries.com
Facebook: https://www.facebook.com/SippIndustries
X: @SippIndustries

About Calypso Pharmaceuticals

Calypso Pharmaceuticals, based in Dallas, Texas, is on a mission to establish a leading global brand with the most comprehensive portfolio of innovative cannabis-based therapeutics.

The company is dedicated to creating products that ensure a healthy and comfortable life, formulating a wide range of medications for chronic conditions such as Alzheimer's, anxiety, chronic pain, depression, melanoma, obesity, and more. Calypso Pharmaceuticals aims to provide a calm and satisfactory experience in administering and utilizing cannabis-based medicine.

Forward Looking Statements:

This release contains forward-looking statements within the meaning of Section 27a of the Securities Act of 1933, as amended and section 21e of the Securities and Exchange Act of 1934, as amended. Those statements include the intent, belief or current expectations of the Company and its management team. Forward-looking statements are projections of events, revenues, income, future economics, research, development, reformulation, product performance or management's plans and objectives for future operations. Some or all of the events or results anticipated by these forward-looking statements may not occur. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Accomplishing the strategy described herein is significantly dependent upon numerous factors, many that are not in management's control.

Contact:

Sipp Industries, Inc.
Investor Relations
ir@sippindustries.com

SOURCE: Sipp Industries Inc.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Vorsicht Crash! So sichere ich mein Aktienportfolio aktiv ab

Der schwarze Montag Anfang August, in Folge der temporären Liquidierung des sogenannten „Yen Carry-Trades“, vernichtete Milliarden an Anlegergeldern. Sogenannte Black Swan Events, also Ereignisse, die nichts und niemand vorhersagen kann, traten zuletzt im März 2020 beim Ausbruch der Corona-Pandemie auf.

Doch wie können Sie sich bei einem derartigen Ausverkauf und Verfall Ihres Depots schützen? Im folgenden kostenlosen Spezialreport wird aufgezeigt, wie man sein Depot mit diversen Strategien und den richtigen Instrumenten versichern kann.

Erweitern Sie Ihr Wissen und handeln Sie zukünftig wie die Profis, um vor dem nächsten schwarzen Schwan ihr Kapital in Sicherheit zu bringen.

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.